TF0023

DRUG2 trials

Sponsors

Techfields Inc

Conditions

COVID-19 PneumoniaIschemic Stroke

Phase 2

A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes

SuspendedNCT02785120

Techfields IncIschemic Stroke

Start: 2017-03-01End: 2024-12-31Target: 225Updated: 2024-01-05

Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults

TerminatedNCT05212818

Techfields IncCOVID-19 Pneumonia

Start: 2022-05-10End: 2023-03-08Updated: 2024-01-08